Antineoplastics/rituximabLack of efficacy: 2 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1981卷 / 1期

关键词：

D O I：

10.1007/s40278-023-48632-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：53 / 53

相关论文

共 50 条

[21] RituximabLack of efficacy: 3 case reports
Reactions Weekly, 2025, 2053 (1) : 327 - 327
[22] RituximabLack of efficacy: 4 case reports
Reactions Weekly, 2023, 1969 (1) : 326 - 326
[23] RituximabLack of efficacy: 6 case reports
Reactions Weekly, 2021, 1865 (1) : 374 - 374
[24] RituximabLack of efficacy: 3 case reports
Reactions Weekly, 2021, 1883 (1) : 323 - 323
[25] RituximabLack of efficacy: 4 case reports
Reactions Weekly, 2023, 1948 (1) : 383 - 383
[26] Antineoplastics/polyethylene glycolLack of efficacy: 2 case reports
Reactions Weekly, 2022, 1918 (1) : 72 - 72
[27] Antineoplastics/unspecified corticosteroidsLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1967 (1) : 60 - 60
[28] Azathioprine/rituximabLack of efficacy and infusion response: 2 case reports
Reactions Weekly, 2025, 2062 (1) : 61 - 61
[29] Immune-globulin/rituximabLack of efficacy : 2 case reports
Reactions Weekly, 2024, 2017 (1) : 241 - 241
[30] Lenalidomide/rituximabLack of efficacy and skin rash: 2 case reports
Reactions Weekly, 2022, 1932 (1) : 346 - 346

← 1 2 3 4 5 →